Trial Profile
Perioperative Low-dose Dexmedetomidine Decreases Incidence of Delirium in Liver Transplant Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Delirium; Sedation
- Focus Therapeutic Use
- 23 Sep 2019 Status changed from recruiting to completed.
- 23 Jan 2018 Planned End Date changed from 1 Feb 2018 to 1 Apr 2018.
- 26 Nov 2017 Planned End Date changed from 1 Jul 2017 to 1 Feb 2018.